Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.
Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.
复制标题
DOI:
10.1371/journal.pone.0132262
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Yehia BR
中科院分区:
文献类型:
--
作者:
Momplaisir FM;Brady KA;Fekete T;Thompson DR;Diez Roux A;Yehia BR
HIV suppression at parturition is beneficial for maternal, fetal and public health. To eliminate mother-to-child transmission of HIV, an understanding of missed opportunities for antiretroviral therapy (ART) use during pregnancy and HIV suppression at delivery is required. We performed a retrospective analysis of 836 mother-to-child pairs involving 656 HIV-infected women in Philadelphia, 2005-2013. Multivariable regression examined associations between patient (age, race/ethnicity, insurance status, drug use) and clinical factors such as adequacy of prenatal care measured by the Kessner index which classifies prenatal care as inadequate, intermediate, or adequate prenatal care; timing of HIV diagnosis; and the outcomes: receipt of ART during pregnancy and viral suppression at delivery. Overall, 25% of the sample was diagnosed with HIV during pregnancy; 39%, 38%, and 23% were adequately, intermediately, and inadequately engaged in prenatal care. Eight-five percent of mother-to-child pairs received ART during pregnancy but only 52% achieved suppression at delivery. Adjusting for patient factors, pairs diagnosed with HIV during pregnancy were less likely to receive ART (AOR 0.39, 95% CI 0.25-0.61) and achieve viral suppression (AOR 0.70, 95% CI 0.49-1.00) than those diagnosed before pregnancy. Similarly, women with inadequate prenatal care were less likely to receive ART (AOR 0.06, 95% CI 0.03-0.11) and achieve viral suppression (AOR 0.31, 95% CI 0.20-0.47) than those with adequate prenatal care. Targeted interventions to diagnose HIV prior to pregnancy and engage HIV-infected women in prenatal care have the potential to improve HIV related outcomes in the perinatal period.
登录
查看更多内容
影响因子:
20.3
作者:
Clerici, M;Saresella, M;Vigano, A
通讯作者:
Vigano, A
DOI:
10.1056/nejmoa0911486
发表时间:
2010-06-17
期刊:
The New England journal of medicine
影响因子:
--
作者:
Chasela CS;Hudgens MG;Jamieson DJ;Kayira D;Hosseinipour MC;Kourtis AP;Martinson F;Tegha G;Knight RJ;Ahmed YI;Kamwendo DD;Hoffman IF;Ellington SR;Kacheche Z;Soko A;Wiener JB;Fiscus SA;Kazembe P;Mofolo IA;Chigwenembe M;Sichali DS;van der Horst CM;BAN Study Group
通讯作者:
BAN Study Group
影响因子:
6.4
作者:
Hatano, Hiroyu;Hayes, Timothy L.;Deeks, Steven G.
通讯作者:
Deeks, Steven G.
DOI:
10.1097/00126334-200204150-00009
发表时间:
2002-04-15
期刊:
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
影响因子:
--
作者:
Cooper, ER;Charurat, M;Blattner, W
通讯作者:
Blattner, W
影响因子:
3.7
作者:
Kirsten, Inga;Sewangi, Julius;Theuring, Stefanie
通讯作者:
Theuring, Stefanie